Immunotherapy Trials: Overcoming the Challenges of Selecting the Correct Patient Population, New Webinar Hosted by Xtalks
One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies
TORONTO, May 15, 2018 (Newswire.com) - There are lots of immunotherapies currently being tested in oncology trials and they are one of the leading forces in oncology drug trials throughout North America and the World. The marketplace is teeming with “the latest” and “the greatest” immunotherapies, but do they work in practice? How can they be brought to market in a practical, cost-efficient manner, that pays due respect to the commercial objectives of the sponsor, and the treatment imperatives of the patient?
Ari VanderWalde, MD, MPH, FACP, Scientific Leader at George Clinical CRO, Director of Clinical Research at West Cancer Center and Associate Vice Chancellor of Clinical Research at University of Tennessee Health Science Center, will give you a no-holds-barred perspective of the trials of the past, how they worked, and insight into successes and failures of those earlier trials. He will use present-day case studies that represent the current landscape and highlight the logistics and challenges that come with running an efficient precision medicine trial. Finally, he will discuss the future of immunotherapy trials: basket/umbrella trials and the most effectual approach to bring the latest and greatest compounds to market. All of this will be based on tried and true experience.
Do not miss this live webinar upcoming on Tuesday, May 22, 2018 at 12 p.m. EDT (5 p.m. BST/UK), if you are the CMO, CEO, COO, Clinical Operations Leader, Outsourcing/Procurement Leader or CSO of pharmaceutical, biotech or organizations with a cellular therapy compound in their pipeline.
Dr. Vanderwalde offers a unique perspective as a clinician, and as a medical leader for an oncology CRO, who has had an extensive career at the forefront throughout the rise of immunotherapy trials.
Dr. VanderWalde will discuss the current and future landscape, along with the benefits of various immunotherapy trial designs, including basket/umbrella trials.
Attendees will:
- Gain firsthand knowledge of the history and growth of cell therapy trials, their challenges, and their benefits
- Learn about the future of cell therapy trials and the impact on sponsors and patients
- Gain insight into the development of efficacious trial design and how partnering with scientific leadership early in the planning stage assists throughout the development process
For more information about this complimentary webinar visit: Immunotherapy Trials: Overcoming the Challenges of Selecting the Correct Patient Population
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical and biotech companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: nrajan@xtalks.com
Source: Xtalks
Related Media
